Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORA74, also known as U19, belongs to the H/ACA class of snoRNAs, which bind core proteins (such as dyskerin, Gar1p, and Nop10p) to form snoRNP complexes[1][5]. SNORA74 is thought to guide the site-specific modification of uridines to pseudouridines mainly in ribosomal RNAs by base-pairing to substrate RNAs, thereby promoting chemical stability and proper assembly of ribosomal subunits[1][2][5]. SNORA74 may be involved in pre-rRNA processing, but its exact biological functions and disease relevance have not been fully elucidated[1]. While many snoRNAs are dysregulated in cancer and other diseases, and some are studied as therapeutic targets, there is no direct evidence that SNORA74 itself is specifically targeted or used as a disease biomarker[2][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORA74 (SNORA74).